Tag Archives: peglispro

December, 2015

  • 4 December

    Eli Lilly Ends Development of its Diabetes Drug

    INDIANAPOLIS, Dec. 4, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that it will cease development of basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, in order to focus research and development efforts on other assets in its portfolio and pipeline. In …